Early myocardial oedema can predict subsequent cardiomyopathy in high‐dose anthracycline therapy

Early myocardial oedema can predict subsequent cardiomyopathy in high‐dose anthracycline therapy

Abstract Aims This study aims to assess subclinical changes in functional and morphologic myocardial MR parameters very early into a repetitive high‐dose anthracycline treatment (planned cumulative dose >650 mg/m2), which may predict subsequent development of anthracycline‐induced cardiomyopathy...

Full description

Bibliographic Details
Main Authors: Fabian Muehlberg, Markus Kornfeld, Leonora Zange, Saeed Ghani, Annette Reichardt, Peter Reichardt, Jeanette Schulz‐Menger
Format: Article
Language:English
Published: Wiley 2023-02-01
Series:ESC Heart Failure
Subjects:
anthracyclines
cardiomyopathy
mapping
cardio‐oncology
MRI
cardiotoxicity
Online Access:https://doi.org/10.1002/ehf2.14232

Internet

https://doi.org/10.1002/ehf2.14232

Similar Items